Navigation path

Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

Autologous Epstein-Barr virus specific T-cells derived from peripheral blood mononuclear cells, expanded ex vivo

EU orphan designation number: EU/3/16/1696   
Active ingredient: Autologous Epstein-Barr virus specific T-cells derived from peripheral blood mononuclear cells, expanded ex vivo
Indication: Treatment of post-transplant lymphoproliferative disorder
Sponsor: Clinical Network Services (NL) B.V.
De Cuserstraat 93, 1081 CN Amsterdam, Noord-Holland, Nederland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
18/07/2016 Orphan designation EMA/OD/076/16 (2016)4681 of 14/07/2016
28/02/2019 Transfer of orphan designation EMA/OD/0000004066 (2019)1747 of 26/02/2019